Research initiative exploring how bioelectric signaling, electrophysiology, and computational systems biology may relate to immune signaling environments, inflammation, and infection associated tissue dynamics.
Research only. No FDA-cleared Electrome infection or immunology therapeutic product currently exists. No claims are made regarding the treatment, cure, mitigation, or prevention of infectious or immunologic disease.
The immune system is a vast and dynamic network of cellular communication, inflammatory signaling, neuroimmune interaction, vascular response, and tissue level coordination.
Researchers across electrophysiology, immunology, and systems biology have increasingly explored how membrane potentials, ion channel behavior, electrical signaling, and bioelectric environments may interact with broader immune and inflammatory dynamics.
Electrome's Infection & Immunology initiative focuses on understanding these systems through computational electrophysiology and bioelectric medicine frameworks.
"The immune system, like the nervous system, is fundamentally a signaling network. Our long term interest is in helping researchers better model the electrical and inflammatory dimensions of those systems."
Inflammation, Infection & Recovery
Inflammation is a central feature of many infectious, immune, and tissue recovery processes. Researchers continue exploring relationships between cytokine signaling, neuroimmune communication, vascular response, autonomic regulation, ion channel behavior, and inflammatory recovery pathways.
Electrome believes future computational systems may eventually help researchers better organize and model these environments. The company's exploratory work includes interest in inflammatory signaling, immune electrophysiology, neuroimmune communication, autonomic interactions, and recovery oriented signaling environments.
Bioelectric Signaling & Immunity
Cells across the immune system maintain electrical states. Membrane potentials, ion channel activity, and electrochemical signaling all influence immune function.
Researchers have studied how bioelectric environments may relate to macrophage behavior, T cell activity, inflammatory cascades, vagal anti-inflammatory pathways, and tissue level immune coordination. These areas remain active fields of ongoing scientific research.
Electrome's interest is focused on computational modeling, signal response mapping, electrophysiology infrastructure, and AI assisted systems biology rather than direct therapeutic claims.
Neuroimmune & Autonomic Signaling
Modern research increasingly emphasizes the bidirectional relationship between the nervous system and the immune system. Vagal signaling, autonomic regulation, neuroinflammation, and cytokine modulation form an interconnected web of biological coordination.
Electrome believes computational electrophysiology may eventually become a useful framework for organizing some of this complexity. Long term areas of exploration include autonomic signaling environments, neuroimmune communication, inflammatory dynamics, and signal response indexing.
Published Borrelia Research
Electrome's first end-to-end Discovery R&D proof point is a preclinical in-vitro study of Borrelia burgdorferi motility under nonthermal extremely low-frequency electromagnetic field exposure. A platform-selected candidate produced a measurable, replicated result on the first experimental day; peer-reviewed publication followed approximately six months after the initial laboratory work.
The paper was published in Frontiers in Medicine on August 11, 2026 by Erik A. Nilsen, Heather Adkison, John R. Martinez, Nevena Zubcevik, and Monica E. Embers. Dr. Embers's current affiliation is the Division of Immunology at the Tulane National Biomedical Research Center, Tulane University.
This is preclinical in-vitro research only. It does not establish a Lyme disease treatment, cure, clinical efficacy, or use in people. No Electrome product is cleared or marketed for Lyme disease or any infectious condition.
"The milestone is a research-workflow proof point: evidence, modeling, protocol design, controlled laboratory work, replication, human review, and peer-reviewed publication."
Clinical Perspective on Persistent Inflammation
From a clinical standpoint, persistent infection associated inflammation, post infectious syndromes, and immune dysregulation can profoundly affect patient quality of life. Conditions like chronic and post treatment Lyme disease, post viral inflammatory states, and dysautonomia associated illnesses share overlapping signaling features that remain incompletely understood.
Electrome's interest in this area is computational and research oriented. The aim is to support better systems level understanding of these signaling environments, not to imply that any current product diagnoses, treats, cures, mitigates, or prevents any infectious or post infectious condition.
"Patients living with persistent post infectious inflammation often fall through the cracks of single system medicine. Better systems level understanding of immune and neuroimmune signaling environments is a meaningful direction for research, even though it does not change current standards of care."
Why This Area Matters
Infectious disease, chronic inflammation, and immune dysregulation collectively represent enormous global healthcare burdens. Researchers continue searching for systems level frameworks capable of modeling immune and inflammatory environments more comprehensively.
Electrome believes future computational bioelectric infrastructure may eventually contribute to that work. The company's long term vision includes Electrome Knowledge Graphs, AI assisted immunology modeling, signal response mapping, and computational systems biology.
"Future medicine will increasingly become computational, integrative, and systems oriented. We believe bioelectric and inflammatory signaling environments may eventually become important infrastructure layers within that future."
Current Literature Context
Published literature involving bioelectric signaling and immunology spans inflammation, ion channel research, neuroimmune signaling, vagal anti-inflammatory pathways, electrophysiology, and systems immunology.
Researchers continue exploring how electrical signaling environments may relate to immune coordination, inflammatory recovery, and tissue level signaling. However, findings remain heterogeneous, indication specific, and frequently preliminary.
Electrome therefore positions this initiative conservatively and within a scientific research framework only.
Current Program Status
The Infection & Immunology initiative remains exploratory, research stage, investigational, and preclinical.
Electrome does not currently market or commercialize infectious disease therapeutics, antimicrobial systems, immunology focused devices, or vaccine platforms. No efficacy or therapeutic claims are made regarding bacterial infection, viral infection, sepsis, autoimmune disease, or immunologic disorders.
Any future infection or immunology applications would require substantial additional research, preclinical validation, clinical studies, and regulatory review. Electrome's current commercial activities remain focused on FDA-cleared pain and recovery infrastructure.
This page is provided for scientific and informational purposes only. The Infection & Immunology initiative, including the published preclinical in-vitro Borrelia research, remains research-stage. Electrome does not market any FDA-cleared infectious disease, antimicrobial, or immunology therapeutic product and makes no claims regarding the treatment, cure, mitigation, or prevention of infectious or immunologic disease. Statements regarding future applications are forward-looking and subject to substantial scientific, clinical, and regulatory uncertainty.
